UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit

Rosen Law Firm issued a solicitation reminding UNCY purchasers (Dec 29, 2025 - Jun 29, 2026 class period) of the November 2, 2026 lead plaintiff deadline in a securities fraud class action. The complaint alleges Unicycive failed to disclose it had not audited its third-party manufacturing vendor's cGMP compliance, creating undisclosed risk of FDA delay for oxylanthanum carbonate (OLC).

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.